K3-innovations, Inc., is a certified minority and woman-owned enterprise founded in 2013 that offers comprehensive clinical trial services.

Over the years, K3 has become a trusted partner in providing robust biometrics, clinical programming, site management, site monitoring, medical writing, regulatory affairs, and pharmacovigilance services.

K3 specializes in high-quality functional services and flexible project solutions for phase I-IV trials. Its skilled professionals deliver innovative, tailored services that support life-saving treatment development. With a client-centric approach focused on exceptional delivery, K3 enables cost-effective and timely clinical trial solutions.

Operating across the US, Canada, and India, K3 leverages a global talent pool to provide comprehensive functional services, ensuring seamless end-to-end support. Our domain expertise, combined with process optimization, drives quality and efficiency for sponsors.

Key capabilities include biometrics (data management, statistical programming, medical coding), clinical operations (project management, monitoring, site management), medical writing, regulatory affairs, and pharmacovigilance solutions.

K3's comprehensive offerings contribute to healthcare advancement and improved patient outcomes. As a minority and woman-owned enterprise, k3 brings fresh perspectives alongside extensive clinical research experience.